Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · MADHAVBAUG

Vaidya Sane Ayurved Laboratories Ltd

HealthcareHealthcare Equipment & Supplies₹170 cr market cap
₹162.50 ▲ +0.0% today As of 19 Nov 2026

Produces Ayurvedic medicines and herbal products. Revenue comes from B2B and retail sales. Focuses on natural sourcing, quality, and regulatory compliance. Operates manufacturing and retail distribution model.

The short version. Return on equity was 12.5% in Mar 2026. Promoter holding was 66.34% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

Change over period: —

2 · The business

Is it growing?

Reported results · ₹ crore

Revenue and profit

Show the numbers

Annual

FY2026FY2025
Revenue10790
Net profit97
Net margin %8.48.0
EPS (₹)8.556.82

3 · The quality

How well does it turn capital into profit?

Return on equity was 12.5% in Mar 2026; debt to equity is 0.04.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %12.511.5
Return on capital %12.515.3
EBITDA margin %16.315.4
Net margin %8.27.8

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.04
Interest cover13.7x
Current ratio3.99
P/E ratio19.1

4 · The owners

Who holds it, and are they adding?

Promoter holding66.34%

Unchanged over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025Dec 2025Mar 2026Sep 2026Change
Promoter66.3466.3466.3466.3466.3466.3466.3466.340.0
FII000000000
DII00000.210000
Public33.6633.6633.6633.6633.4533.6633.6633.660.0

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for Vaidya Sane Ayurved Laboratories Ltd are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about Vaidya Sane Ayurved Laboratories Ltd

What is the Vaidya Sane Ayurved Laboratories Ltd share price?

Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) last closed at ₹162.50, up 0.0% on the day.

What is the market cap of Vaidya Sane Ayurved Laboratories Ltd?

Vaidya Sane Ayurved Laboratories Ltd has a market capitalisation of about ₹170 crore. Its price-to-earnings ratio is 19.1.

How are Vaidya Sane Ayurved Laboratories Ltd's latest results?

Return on equity was 12.5% in Mar 2026. Promoter holding was 66.34% in Sep 2026, up 0.00 points over 8 quarters.

Who owns Vaidya Sane Ayurved Laboratories Ltd?

As of Sep 2026, shareholding was: Promoter 66.34%, Public 33.66%.

How many mutual funds hold Vaidya Sane Ayurved Laboratories Ltd?

0 mutual fund schemes held Vaidya Sane Ayurved Laboratories Ltd in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 05 Sep 2023 · Dividend - Rs. 0.25
  • 18 Nov 2022 · Interim Dividend - Rs. 0.25

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.